These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 11382868

  • 1. Sleep-wake and eeg effects following adenosine a1 agonism and antagonism: similarities and interactions with sleep-wake and eeg effects following a serotonin reuptake inhibitor in rats.
    Ursin R, Bjorvatn B.
    Sleep Res Online; 1998; 1(3):119-27. PubMed ID: 11382868
    [Abstract] [Full Text] [Related]

  • 2. Sleep/waking and EEG power spectrum effects of a nonselective serotonin (5-HT) antagonist and a selective 5-HT reuptake inhibitor given alone and in combination.
    Bjorvatn B, Bjørkum AA, Neckelmann D, Ursin R.
    Sleep; 1995 Jul; 18(6):451-62. PubMed ID: 7481417
    [Abstract] [Full Text] [Related]

  • 3. Effects of zimeldine, a selective 5-HT reuptake inhibitor, combined with ritanserin, a selective 5-HT2 antagonist, on waking and sleep stages in rats.
    Bjorvatn B, Ursin R.
    Behav Brain Res; 1990 Nov 30; 40(3):239-46. PubMed ID: 2149499
    [Abstract] [Full Text] [Related]

  • 4. Behavioral, sleep-waking and EEG power spectral effects following the two specific 5-HT uptake inhibitors zimeldine and alaproclate in cats.
    Sommerfelt L, Ursin R.
    Behav Brain Res; 1991 Nov 26; 45(2):105-15. PubMed ID: 1838688
    [Abstract] [Full Text] [Related]

  • 5. Increased waking as well as increased synchronization following administration of selective 5-HT uptake inhibitors to rats.
    Ursin R, Bjorvatn B, Sommerfelt L, Underland G.
    Behav Brain Res; 1989 Aug 01; 34(1-2):117-30. PubMed ID: 2527519
    [Abstract] [Full Text] [Related]

  • 6. The 5-HT1A antagonist (-)-alprenolol fails to modify sleep or zimeldine-induced sleep-waking effects in rats.
    Bjorvatn B, Neckelmann D, Ursin R.
    Pharmacol Biochem Behav; 1992 May 01; 42(1):49-56. PubMed ID: 1388278
    [Abstract] [Full Text] [Related]

  • 7. The effects of zimeldine and alaproclate combined with a small dose of 5-HTP on waking and sleep stages in cats.
    Sommerfelt L, Ursin R.
    Behav Brain Res; 1987 Apr 01; 24(1):1-10. PubMed ID: 2953350
    [Abstract] [Full Text] [Related]

  • 8. Similar effect on REM sleep but differential effect on slow wave sleep of the two 5-HT uptake inhibitors zimeldine and alaproclate in cats and rats.
    Sommerfelt L, Hauge ER, Ursin R.
    J Neural Transm; 1987 Apr 01; 68(1-2):127-44. PubMed ID: 2949058
    [Abstract] [Full Text] [Related]

  • 9. The 5-HT2 antagonist ritanserin decreases sleep in cats.
    Sommerfelt L, Ursin R.
    Sleep; 1993 Jan 01; 16(1):15-22. PubMed ID: 8456229
    [Abstract] [Full Text] [Related]

  • 10. Sleep and EEG power spectrum effects of the 5-HT1A antagonist NAN-190 alone and in combination with citalopram.
    Neckelmann D, Bjørkum AA, Bjorvatn B, Ursin R.
    Behav Brain Res; 1996 Feb 01; 75(1-2):159-68. PubMed ID: 8800653
    [Abstract] [Full Text] [Related]

  • 11. Diurnal differences in L-tryptophan sleep and temperature effects in the rat.
    Olsen OE, Neckelmann D, Ursin R.
    Behav Brain Res; 1994 Dec 15; 65(2):195-203. PubMed ID: 7718152
    [Abstract] [Full Text] [Related]

  • 12. Lesion of descending 5-HT pathways increases zimeldine-induced waking in rats.
    Bjørkum AA, Neckelmann D, Bjorvatn B, Ursin R.
    Physiol Behav; 1995 May 15; 57(5):959-66. PubMed ID: 7610150
    [Abstract] [Full Text] [Related]

  • 13. Citalopram: differential sleep/wake and EEG power spectrum effects after single dose and chronic administration.
    Neckelmann D, Bjorvatn B, Bjørkum AA, Ursin R.
    Behav Brain Res; 1996 Sep 15; 79(1-2):183-92. PubMed ID: 8883829
    [Abstract] [Full Text] [Related]

  • 14. Acute administration of the novel serotonin and noradrenaline reuptake inhibitor, S33005, markedly modifies sleep-wake cycle architecture in the rat.
    Cespuglio R, Rousset C, Debilly G, Rochat C, Millan MJ.
    Psychopharmacology (Berl); 2005 Oct 15; 181(4):639-52. PubMed ID: 15983796
    [Abstract] [Full Text] [Related]

  • 15. Effects of the selective 5-hydroxytryptamine uptake inhibitors paroxetine and zimeldine on EEG sleep and waking stages in the rat.
    Kleinlogel H, Burki HR.
    Neuropsychobiology; 1987 Oct 15; 17(4):206-12. PubMed ID: 2964564
    [Abstract] [Full Text] [Related]

  • 16. Differential effects of adenosine receptor subtypes on release and reuptake of hippocampal serotonin.
    Okada M, Kawata Y, Murakami T, Wada K, Mizuno K, Kondo T, Kaneko S.
    Eur J Neurosci; 1999 Jan 15; 11(1):1-9. PubMed ID: 9987006
    [Abstract] [Full Text] [Related]

  • 17. Chronic zimeldine administration to cats: sustained increase of serotonergic effect as measured with sleep parameters.
    Sommerfelt L.
    Pharmacol Toxicol; 1990 Feb 15; 66(2):128-32. PubMed ID: 2138291
    [Abstract] [Full Text] [Related]

  • 18. The adenosine kinase inhibitor ABT-702 augments EEG slow waves in rats.
    Radek RJ, Decker MW, Jarvis MF.
    Brain Res; 2004 Nov 05; 1026(1):74-83. PubMed ID: 15476699
    [Abstract] [Full Text] [Related]

  • 19. A selective serotonin reuptake inhibitor reduces REM sleep in the homing pigeon.
    Fuchs T, Siegel JJ, Burgdorf J, Bingman VP.
    Physiol Behav; 2006 Mar 30; 87(3):575-81. PubMed ID: 16469340
    [Abstract] [Full Text] [Related]

  • 20. Chronic escitalopram treatment caused dissociative adaptation in serotonin (5-HT) 2C receptor antagonist-induced effects in REM sleep, wake and theta wave activity.
    Kostyalik D, Kátai Z, Vas S, Pap D, Petschner P, Molnár E, Gyertyán I, Kalmár L, Tóthfalusi L, Bagdy G.
    Exp Brain Res; 2014 Mar 30; 232(3):935-46. PubMed ID: 24395141
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.